Connexion Mobility reports robust Q2 FY25 results with revenue and net profit surging, driven by subscription growth and strategic product launches. The company’s focus on user engagement and marketplace expansion signals promising long-term shareholder value.
Memphasys Limited has secured a major scientific endorsement for its RoXsta™ antioxidant profiling system, positioning the technology for expanded clinical and agricultural applications.
